Position in TGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,919,336
New position
Shares Held
358,800
first reported quarter
Ownership
0.234%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRAIDWELL LP holds $1,648,117,197 across 48 Biotechnology names. TGTX ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
8,009,447 | $143,208,912 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
1,986,768 | $78,914,424 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
1,338,452 | $77,830,983 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
899,364 | $75,474,626 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
2,347,583 | $73,948,864 | |
| 6 | NUVL |
Nuvalent, Inc.
|
700,429 | $71,758,951 | |
| 7 | KOD |
Kodiak Sciences Inc.
|
1,818,665 | $69,327,509 | |
| 8 | CGON |
CG Oncology, Inc.
|
984,783 | $66,650,113 |
All Filings in TGTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,919,336 | 358,800 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||